论文部分内容阅读
目的探讨高强度聚焦超声(high-intensity focused ultrasound,HIFU)治疗肝脏肿瘤的近期疗效。方法对118例接受HIFU治疗的肝癌患者,分析治疗前后临床症状、AFP、肝功能、影像学变化以及术后并发症的发生情况。结果 HIFU治疗后,临床症状缓解率54.5%(42/77);59.4%(41/69)的患者血清AFP下降;91.6%(99/108)的患者术后早期影像学检查提示治疗有效,主要表现为治疗区域出现不同程度的组织坏死,血供消失或减少;术后并发症少。结论 HIFU治疗肝脏肿瘤是有效和可行的,为临床治疗肝脏肿瘤提供一种新的治疗手段。
Objective To investigate the short-term curative effect of high-intensity focused ultrasound (HIFU) on liver tumors. Methods A total of 118 HCC patients treated with HIFU were enrolled in this study. Clinical symptoms, AFP, liver function, imaging changes and postoperative complications were analyzed before and after treatment. Results After HIFU treatment, the clinical symptom relief rate was 54.5% (42/77); the serum AFP level was decreased in 59.4% (41/69) patients; the early postoperative imaging examination in 91.6% (99/108) The performance of the treatment area of varying degrees of tissue necrosis, blood loss or decrease; less postoperative complications. Conclusion HIFU treatment of liver tumors is effective and feasible for the treatment of liver tumors provide a new treatment.